FDA updates promethazine hydrochloride injection labeling
Changes mitigate risk of irritation and tissue damage
Changes mitigate risk of irritation and tissue damage
Ads must present risks in clear, conspicuous and neutral ways
Discusses issues difficult to address in the context of a rare disease
Added language intends to enable safer use of opioid pain medicines
GeMDAC will advise on treatment safety and effectiveness
Event covers global clinical trials, bioequivalence and pharmacovigilance
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.